Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,504

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

February 29, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo identical to BI 10773 high dose

Placebo tablets matching BI 10773 high dose

DRUG

Placebo identical to BI 10773 low dose

Placebo tablets matching BI 10773 low dose

DRUG

BI 10773

BI 10773 tablets once daily high dose open label

DRUG

BI 10773

BI 10773 tablets once daily high dose

DRUG

Placebo identical to BI 10773 low dose

Placebo tablets matching BI 10773 low dose

DRUG

BI 10773

BI 10773 tablets once daily low dose

DRUG

Placebo identical to BI 10773 high dose

Placebo tablets matching BI 10773 high dose

Trial Locations (148)

Unknown

1245.23.10145 Boehringer Ingelheim Investigational Site, Birmingham

1245.23.10046 Boehringer Ingelheim Investigational Site, Tempe

1245.23.10095 Boehringer Ingelheim Investigational Site, Huntington Park

1245.23.10109 Boehringer Ingelheim Investigational Site, Huntington Park

1245.23.10074 Boehringer Ingelheim Investigational Site, Los Angeles

1245.23.10149 Boehringer Ingelheim Investigational Site, Rancho Cucamonga

1245.23.10127 Boehringer Ingelheim Investigational Site, Waterbury

1245.23.10042 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1245.23.10133 Boehringer Ingelheim Investigational Site, Jupiter

1245.23.10080 Boehringer Ingelheim Investigational Site, Decatur

1245.23.10001 Boehringer Ingelheim Investigational Site, Chicago

1245.23.10159 Boehringer Ingelheim Investigational Site, Des Moines

1245.23.10117 Boehringer Ingelheim Investigational Site, Arkansas City

1245.23.10157 Boehringer Ingelheim Investigational Site, Newton

1245.23.10148 Boehringer Ingelheim Investigational Site, Lexington

1245.23.10034 Boehringer Ingelheim Investigational Site, Rochester

1245.23.10123 Boehringer Ingelheim Investigational Site, Smithtown

1245.23.10120 Boehringer Ingelheim Investigational Site, Columbus

1245.23.10031 Boehringer Ingelheim Investigational Site, Oklahoma City

1245.23.10158 Boehringer Ingelheim Investigational Site, Mt. Pleasant

1245.23.10015 Boehringer Ingelheim Investigational Site, Simpsonville

1245.23.10156 Boehringer Ingelheim Investigational Site, Houston

1245.23.10153 Boehringer Ingelheim Investigational Site, Hurst

1245.23.10143 Boehringer Ingelheim Investigational Site, Killeen

1245.23.10106 Boehringer Ingelheim Investigational Site, San Antonio

1245.23.20032 Boehringer Ingelheim Investigational Site, Calgary

1245.23.20023 Boehringer Ingelheim Investigational Site, Edmonton

1245.23.20028 Boehringer Ingelheim Investigational Site, Vancouver

1245.23.20033 Boehringer Ingelheim Investigational Site, Victoria

1245.23.20024 Boehringer Ingelheim Investigational Site, Paradise

1245.23.20031 Boehringer Ingelheim Investigational Site, St. John's

1245.23.20026 Boehringer Ingelheim Investigational Site, Halifax

1245.23.20001 Boehringer Ingelheim Investigational Site, Barrie

1245.23.20022 Boehringer Ingelheim Investigational Site, Brampton

1245.23.20035 Boehringer Ingelheim Investigational Site, Corunna

1245.23.20030 Boehringer Ingelheim Investigational Site, Etobicoke

1245.23.20037 Boehringer Ingelheim Investigational Site, Hamilton

1245.23.20029 Boehringer Ingelheim Investigational Site, London

1245.23.20003 Boehringer Ingelheim Investigational Site, Markham

1245.23.20040 Boehringer Ingelheim Investigational Site, Oakville

1245.23.20034 Boehringer Ingelheim Investigational Site, Sarnia

1245.23.20039 Boehringer Ingelheim Investigational Site, Toronto

1245.23.20027 Boehringer Ingelheim Investigational Site, Laval

1245.23.20025 Boehringer Ingelheim Investigational Site, Montreal

1245.23.20038 Boehringer Ingelheim Investigational Site, Saint-Laurent

1245.23.20036 Boehringer Ingelheim Investigational Site, Sherbrooke

1245.23.86031 Boehringer Ingelheim Investigational Site, Beijing

1245.23.86032 Boehringer Ingelheim Investigational Site, Beijing

1245.23.86033 Boehringer Ingelheim Investigational Site, Beijing

1245.23.86034 Boehringer Ingelheim Investigational Site, Beijing

1245.23.86035 Boehringer Ingelheim Investigational Site, Beijing

1245.23.86048 Boehringer Ingelheim Investigational Site, Chengdu

1245.23.86058 Boehringer Ingelheim Investigational Site, Chongqing

1245.23.86038 Boehringer Ingelheim Investigational Site, Dalian

1245.23.86002 Boehringer Ingelheim Investigational Site, Guangzhou

1245.23.86052 Boehringer Ingelheim Investigational Site, Guangzhou

1245.23.86037 Boehringer Ingelheim Investigational Site, Haerbin

1245.23.86049 Boehringer Ingelheim Investigational Site, Jinan

1245.23.86053 Boehringer Ingelheim Investigational Site, Jinan

1245.23.86042 Boehringer Ingelheim Investigational Site, Nanjing

1245.23.86043 Boehringer Ingelheim Investigational Site, Nanjing

1245.23.86055 Boehringer Ingelheim Investigational Site, Nanning

1245.23.86056 Boehringer Ingelheim Investigational Site, Nanning

1245.23.86039 Boehringer Ingelheim Investigational Site, Shanghai

1245.23.86040 Boehringer Ingelheim Investigational Site, Shanghai

1245.23.86054 Boehringer Ingelheim Investigational Site, Shantou

1245.23.86057 Boehringer Ingelheim Investigational Site, Shenyang

1245.23.86045 Boehringer Ingelheim Investigational Site, Shijiazhuang

1245.23.86013 Boehringer Ingelheim Investigational Site, Suzhou

1245.23.86036 Boehringer Ingelheim Investigational Site, Tianjin

1245.23.86041 Boehringer Ingelheim Investigational Site, Xi'an

1245.23.86051 Boehringer Ingelheim Investigational Site, Zhenjiang

1245.23.33015 Boehringer Ingelheim Investigational Site, Arras

1245.23.33008 Boehringer Ingelheim Investigational Site, Bersée

1245.23.33020 Boehringer Ingelheim Investigational Site, Bischheim

1245.23.33002 Boehringer Ingelheim Investigational Site, Bondy

1245.23.33016 Boehringer Ingelheim Investigational Site, Bruay-la-Buissière

1245.23.33001 Boehringer Ingelheim Investigational Site, Corbeil-Essonnes

1245.23.33010 Boehringer Ingelheim Investigational Site, Croix

1245.23.33009 Boehringer Ingelheim Investigational Site, Hautmont

1245.23.33003 Boehringer Ingelheim Investigational Site, La Rochelle

1245.23.33045 Boehringer Ingelheim Investigational Site, Marseille

1245.23.33014 Boehringer Ingelheim Investigational Site, Mundolsheim

1245.23.33004 Boehringer Ingelheim Investigational Site, Narbonne

1245.23.33012 Boehringer Ingelheim Investigational Site, Schiltigheim

1245.23.33013 Boehringer Ingelheim Investigational Site, Strasbourg

1245.23.33019 Boehringer Ingelheim Investigational Site, Strasbourg

1245.23.33007 Boehringer Ingelheim Investigational Site, Vieux-Condé

1245.23.33018 Boehringer Ingelheim Investigational Site, Wattrelos

1245.23.49001 Boehringer Ingelheim Investigational Site, Dormagen

1245.23.49009 Boehringer Ingelheim Investigational Site, Flörsheim

1245.23.49004 Boehringer Ingelheim Investigational Site, Hatten

1245.23.49007 Boehringer Ingelheim Investigational Site, Künzing

1245.23.49002 Boehringer Ingelheim Investigational Site, Neuwied

1245.23.49008 Boehringer Ingelheim Investigational Site, Nuremberg

1245.23.49010 Boehringer Ingelheim Investigational Site, Rednitzhembach

1245.23.49006 Boehringer Ingelheim Investigational Site, Rehburg-Loccum

1245.23.49011 Boehringer Ingelheim Investigational Site, Rehlingen-Siersburg

1245.23.49005 Boehringer Ingelheim Investigational Site, Saarbrücken

1245.23.49003 Boehringer Ingelheim Investigational Site, Unterschneidheim

1245.23.91101 Boehringer Ingelheim Investigational Site, Coimbatore

1245.23.91104 Boehringer Ingelheim Investigational Site, Indore

1245.23.91103 Boehringer Ingelheim Investigational Site, Maharashtra

1245.23.91102 Boehringer Ingelheim Investigational Site, Nagpur

1245.23.91105 Boehringer Ingelheim Investigational Site, Pune

1245.23.52003 Boehringer Ingelheim Investigational Site, Guadalajara

1245.23.52004 Boehringer Ingelheim Investigational Site, Guadalajara

1245.23.52001 Boehringer Ingelheim Investigational Site, Monterrey

1245.23.52002 Boehringer Ingelheim Investigational Site, Monterrey

1245.23.74005 Boehringer Ingelheim Investigational Site, Bratislava

1245.23.74002 Boehringer Ingelheim Investigational Site, Lučenec

1245.23.74006 Boehringer Ingelheim Investigational Site, Nitra

1245.23.74014 Boehringer Ingelheim Investigational Site, Nové Zámky

1245.23.74001 Boehringer Ingelheim Investigational Site, Považská Bystrica

1245.23.74004 Boehringer Ingelheim Investigational Site, Prešov

1245.23.74003 Boehringer Ingelheim Investigational Site, Trebišov

1245.23.38003 Boehringer Ingelheim Investigational Site, Celje

1245.23.38002 Boehringer Ingelheim Investigational Site, Koper

1245.23.38001 Boehringer Ingelheim Investigational Site, Maribor

1245.23.82012 Boehringer Ingelheim Investigational Site, Anyang

1245.23.82004 Boehringer Ingelheim Investigational Site, Busan

1245.23.82011 Boehringer Ingelheim Investigational Site, Goyang

1245.23.82009 Boehringer Ingelheim Investigational Site, Ilsan

1245.23.82001 Boehringer Ingelheim Investigational Site, Incheon

1245.23.82006 Boehringer Ingelheim Investigational Site, Jeonju

1245.23.82005 Boehringer Ingelheim Investigational Site, Seoul

1245.23.82007 Boehringer Ingelheim Investigational Site, Seoul

1245.23.82008 Boehringer Ingelheim Investigational Site, Seoul

1245.23.82010 Boehringer Ingelheim Investigational Site, Seoul

1245.23.82014 Boehringer Ingelheim Investigational Site, Seoul

1245.23.82002 Boehringer Ingelheim Investigational Site, Suwon

1245.23.82003 Boehringer Ingelheim Investigational Site, Wŏnju

1245.23.88010 Boehringer Ingelheim Investigational Site, Kaohsiung City

1245.23.88011 Boehringer Ingelheim Investigational Site, Kaohsiung City

1245.23.88012 Boehringer Ingelheim Investigational Site, Kaohsiung City

1245.23.88013 Boehringer Ingelheim Investigational Site, Kaohsiung City

1245.23.88009 Boehringer Ingelheim Investigational Site, Taichung

1245.23.88014 Boehringer Ingelheim Investigational Site, Tainan City

1245.23.88006 Boehringer Ingelheim Investigational Site, Taipei

1245.23.88007 Boehringer Ingelheim Investigational Site, Taipei

1245.23.88021 Boehringer Ingelheim Investigational Site, Taipei

1245.23.88008 Boehringer Ingelheim Investigational Site, Taoyuan

1245.23.90003 Boehringer Ingelheim Investigational Site, Erzurum

1245.23.90001 Boehringer Ingelheim Investigational Site, Gaziantep

1245.23.90002 Boehringer Ingelheim Investigational Site, Istanbul

1245.23.90006 Boehringer Ingelheim Investigational Site, Istanbul

1245.23.90007 Boehringer Ingelheim Investigational Site, Istanbul

1245.23.90004 Boehringer Ingelheim Investigational Site, Izmir

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY